Tumor molecular profiling is a fundamental component of precision oncology, enabling the
identification of genomic alterations in genes and pathways that can be targeted …

Acquired mutations are pervasive across normal tissues. However, understanding of the
processes that drive transformation of certain clones to cancer is limited. Here we study this …

Background Addition of trastuzumab to first-line chemotherapy improves overall survival in
patients with HER2-positive metastatic gastric cancer. We assessed the safety and activity of …

Purpose: Various genetic driver aberrations have been identified among distinct anatomic
and clinical subtypes of intrahepatic and extrahepatic cholangiocarcinoma, and these …

Purpose: Targeted next-generation sequencing of DNA has become more widely used in
the management of patients with lung adenocarcinoma; however, no clear mitogenic driver …

Introduction Highly aggressive thoracic neoplasms characterized by SMARCA4 (BRG1)
deficiency and undifferentiated round cell or rhabdoid morphology have been recently …

Circulating cell-free DNA from blood plasma of cancer patients can be used to non-invasively
interrogate somatic tumor alterations. Here we develop MSK-ACCESS (Memorial Sloan …

TRK fusions are found in a variety of cancer types, lead to oncogenic addiction, and strongly
predict tumor-agnostic efficacy of TRK inhibition 1 , 2 , 3 , 4 , 5 , 6 , 7 – 8 . With the recent …

Purpose: Molecular profiling in cancer has identified potential actionable drug targets that
have prompted attempts to discover clinically validated biomarkers to guide therapeutic …

Target identification is highly instructive in defining the biological roles of microRNAs.
However, little is known about other small noncoding RNAs; for example, tRNA-derived RNA …